Stay updated with breaking news from Precision Interventions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease that inevitably results in respiratory failure and death within 3 to 5 years of
Is it ready for prime time or is it just a toy with possible serious consequences?
A new medication has been added to the treatment options for children with moderate-to-severe asthma. In a late-stage clinical trial, the biologic agent dupilumab reduced the rate of severe asthma attacks and improved lung function and asthma control for children ages 6 to 11.
New study focuses on personalized therapies for people with severe asthma A new phase 2 clinical trial of multiple therapies for severe asthma is underway in Northeast Ohio, with a focus on personalized therapies based on genetics, family history, lifestyle and environmental factors. The Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network (PrecISE) study, sponsored by the National Heart, Lung and Blood Institute (NHBLI), is enrolling patients at Cleveland Clinic and University Hospitals Rainbow Babies & Children's Hospital. The multicenter study involves 30 clinical si...
Why people with asthma seem to be protected from severe COVID-19